SBSimon Hill MSc, BSc
@theproof · X
@Carnket @drmatthewnagra @ChrisMasterjohn @AlexJLeaf https://t.co/CPvtfELg4S
Dec 21, 2020 · 34,348 followers
View post →
Osteoporos Int September 2013 PMID 23525894
Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Mentions
4
Peak: 1 in Dec 2020
across 2 sources since Dec 2020
Extended reach
56,587
potential audience
Total likes
675
Video views
22,173
Mentions per month
Dec 2020 – Apr 2025Where it's discussed
-
X / Twitter2 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions highlight the significance of vitamin K, especially menaquinone-7, in improving bone health, with phrases like 'powerful micronutrient' and 'significantly improve & reduce bone mass loss,' showcasing recognition of the research's potential. The tone is focused and appreciative, reflecting genuine interest and moderate engagement in the topic's implications for aging and health.
AgreementModerate agreement
Most discussions recognize the positive findings of the study and acknowledge the benefits of menaquinone-7 for bone health in postmenopausal women.
InterestHigh interest
The discussions reflect a high interest, emphasizing the importance of vitamin K in aging and bone maintenance.
EngagementModerate engagement
Participants refer to specific details about how menaquinone-7 improves bone density, indicating moderate engagement.
ImpactModerate impact
The posts suggest that people view this research as impactful for health, especially in aging populations, though not claiming revolutionary change.
Abstract in brief
- Three-year low-dose menaquinone 7 (MK7) supplementation improves vitamin K status and helps reduce age-related bone loss and decline in bone mineral density (BMD) and strength at key areas like the lumbar spine and femoral neck in healthy postmenopausal women.
- The study found that MK7 significantly decreased vertebral height loss and increased bone strength, with measurements showing positive effects after 1, 2, and 3 years of treatment, highlighting its potential to prevent bone deterioration in this group.
- Despite mixed results in previous research, this investigation supports the idea that low-dose MK7 can be beneficial for maintaining bone health in postmenopausal women, aligning with regulatory opinions on vitamin K’s role in supporting bone maintenance.]
Top posts
Most liked on X and Bluesky
CCalerieLife
@CalerieLife · X
Vitamin K is a powerful Micronutrient in aging. Menaquinone-7 is a form of vitamin K. In older women, it demonstrated to significantly improve & reduce bone mass density & bone mass loss at part of the lumbar spine and bone in the thighs. https://t.co/G82vXPoI1R
May 26, 2022 · 66 followers
View post →
All mentions
Vitamin K2: Unique Roles and Need for Separate RDI
Vitamin K2's distinct structure and mechanisms influence bone and cardiovascular health. This video explores its potential indications, efficacy, safety, and the importance of establishing a separate recommended daily…
Olexiy Pukhov - Knowledge Translation · Apr 16, 2021
19,833 views
Enhancing Bone Health with Vitamin K and D Supplementation
A meta-analysis of eight trials shows that combining vitamin K2 with vitamin D improves bone density and reduces markers of poor bone health, offering effective strategies for osteoporosis prevention.
DR das Dietas · Apr 16, 2025
2,340 views
CalerieLife
@CalerieLife · X
Vitamin K is a powerful Micronutrient in aging. Menaquinone-7 is a form of vitamin K. In older women, it demonstrated to significantly improve & reduce bone mass density & bone mass loss at part of the lumbar spine and bone in the thighs. https://t.co/G82vXPoI1R
May 26, 2022 · 66 followers
View post →
Simon Hill MSc, BSc
@theproof · X
@Carnket @drmatthewnagra @ChrisMasterjohn @AlexJLeaf https://t.co/CPvtfELg4S
Dec 21, 2020 · 34,348 followers
View post →
No mentions from this source yet.